Drug Discovery · Biotechnology
AirNexis news and milestones
AirNexis: 11 headlines on record, 1 headline in the last 90 days.
Data updated Nov 17, 2026 · Back to the company report
11Headlines
1In 90 days
0Milestones
Headlines
Sep 82026
Blog
The post AirNexis Announces that AN01 Met its Primary Endpoint in a Phase 2b COPD Study appeared first on AirNexis.
Jan 122026
News · news.qq.com
近日海思科宣布与美国AirNexis公司签订独占许可协议授予后者在除中国大陆、中国香港特别行政区、中国澳门特别行政区及中国台湾地区以外的全球范围内开发、生产和商业化HSK39004的独家权利根据协议AirNexis将向海思科支付1.08亿美元首付款(含4000万美元现金及等值约6800万美元的AirNexis公司19.9%股权)以及最高9....
Jan 112026
News · Pulse 2.0
AirNexis Therapeutics has launched as a clinical-stage biotechnology company focused on pulmonary diseases, closing a $200 million Series A financing and securing an in-license t…
Jan 102026
News · finance.sina.com.cn
1月9日晚间海思科公告称公司与美国AirNexis Therapeutics, Inc.AirNexis签订独占许可协议授予AirNexis在除中国以外的全球范围内开发、生产和商业化HSK39004的独家权利本次交易构成共同投资...
Jan 92026
News · news.qq.com
每经AI快讯1月9日海思科公告称公司与美国AirNexis Therapeutics, Inc.签订独占许可协议授予AirNexis在除中国大陆、香港、澳门及台湾地区以外的全球范围内开发、生产和商业化HSK39004的独家权利AirNexis将向海思科支付1.08亿美元首付款含4000万美元现金及等值约6800万美元的AirNexis公司19.9%股权及…
Jan 92026
Jan 92026
Press release · businesswire.com
AirNexis acquires exclusive rights to develop AN01 outside of China from Haisco Pharmaceutical Group
Jan 92026
News · finance.eastmoney.com
人民财讯1月9日电海思科(002653)1月9日公告公司与美国AirNexisTherapeutics,Inc.简称
Jan 92026
News · finance.eastmoney.com
北京商报讯1月9日晚间海思科002653发布公告称公司与美国AirNexisTherapeutics,Inc.曾用名DragonwellBiosciences,Inc.以下简称
Jan 92026
News · YahooFinance
PALO ALTO, Calif., January 09, 2026--AirNexis Therapeutics, a clinical stage biotech company developing therapeutics for pulmonary diseases, today announced the close of a $200 m…
Sources: the outlets named on each headline, each story once
How to cite
AirNexis, News. Alion, Nov 17, 2026. https://alion.io/company/world-13/news
